1. Home
  2. VCIG vs INAB Comparison

VCIG vs INAB Comparison

Compare VCIG & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCIG
  • INAB
  • Stock Information
  • Founded
  • VCIG 2013
  • INAB 2016
  • Country
  • VCIG Malaysia
  • INAB United States
  • Employees
  • VCIG N/A
  • INAB N/A
  • Industry
  • VCIG Diversified Commercial Services
  • INAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • VCIG Consumer Discretionary
  • INAB Health Care
  • Exchange
  • VCIG Nasdaq
  • INAB Nasdaq
  • Market Cap
  • VCIG 15.6M
  • INAB 14.5M
  • IPO Year
  • VCIG 2023
  • INAB 2021
  • Fundamental
  • Price
  • VCIG $2.24
  • INAB $2.17
  • Analyst Decision
  • VCIG
  • INAB Strong Buy
  • Analyst Count
  • VCIG 0
  • INAB 2
  • Target Price
  • VCIG N/A
  • INAB $108.00
  • AVG Volume (30 Days)
  • VCIG 1.4M
  • INAB 383.7K
  • Earning Date
  • VCIG 08-18-2025
  • INAB 08-07-2025
  • Dividend Yield
  • VCIG N/A
  • INAB N/A
  • EPS Growth
  • VCIG N/A
  • INAB N/A
  • EPS
  • VCIG 54.73
  • INAB N/A
  • Revenue
  • VCIG $27,819,290.00
  • INAB N/A
  • Revenue This Year
  • VCIG N/A
  • INAB N/A
  • Revenue Next Year
  • VCIG N/A
  • INAB N/A
  • P/E Ratio
  • VCIG $0.04
  • INAB N/A
  • Revenue Growth
  • VCIG 36.99
  • INAB N/A
  • 52 Week Low
  • VCIG $2.05
  • INAB $2.06
  • 52 Week High
  • VCIG $607.60
  • INAB $27.60
  • Technical
  • Relative Strength Index (RSI)
  • VCIG 35.13
  • INAB 27.49
  • Support Level
  • VCIG $3.04
  • INAB $2.06
  • Resistance Level
  • VCIG $3.03
  • INAB $2.31
  • Average True Range (ATR)
  • VCIG 0.30
  • INAB 0.31
  • MACD
  • VCIG 0.01
  • INAB -0.00
  • Stochastic Oscillator
  • VCIG 5.84
  • INAB 4.74

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development solution consultancy. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology Consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment which focuses on listing solutions, investor relations, and boardroom strategies consultancy. It has established a diverse local and international clientele, providing them with its services in both local and cross-border listings. Its role begins with pre-listing diagnosis and planning to the finalization of the entire listing process.

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

Share on Social Networks: